
OpenAI Researcher Miles Wang Is in Talks to Launch a $2 Billion AI Drug Discovery Startup
OpenAI researcher Miles Wang is reportedly launching an AI drug discovery startup, signaling soaring investor interest in biotech AI.
Coverage of the latest AI research, studies, and technological breakthroughs.

OpenAI researcher Miles Wang is reportedly launching an AI drug discovery startup, signaling soaring investor interest in biotech AI.

DeepMind CEO Demis Hassabis wants an independent standards body for frontier AI regulation, modeled on FINRA and backed by government.

A new report says YouTube and X sent millions to nudify apps, exposing how mainstream platforms help spread nonconsensual explicit deepfakes.

Open models are taking share from frontier labs as enterprises seek cheaper, customizable AI and less vendor lock-in.

Demis Hassabis urges a US-led AI watchdog to review frontier models and slow risky releases as AGI concerns grow.

The ELIZA effect shaped the first chatbot and still explains why people trust ChatGPT-like systems with private thoughts.

PixVerse says its video generation round reached $439M, pushing valuation above $2B as it expands world models and global sales.

Altman’s jab at Musk spotlights why space data centers remain a long-shot: launch costs, reuse limits and scale still block the business.

George Hotz’s provocative case for user-controlled AI reignites the AI safety debate over freedom, misuse and model alignment.

A Danish study shows quantum computing can improve an AI peptide discovery model, hinting at faster vaccines and immunotherapies.